Yuhan Corporation (000105.KS)
KRW 101900.0
(-3.04%)
KRW 101900.0
(-3.04%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 2814.07 Billion KRW | 13.8% |
| 2022 | 2472.72 Billion KRW | 0.36% |
| 2021 | 2463.81 Billion KRW | 2.94% |
| 2020 | 2393.52 Billion KRW | 13.05% |
| 2019 | 2117.2 Billion KRW | -2.6% |
| 2018 | 2173.81 Billion KRW | 3.78% |
| 2017 | 2094.67 Billion KRW | 2.38% |
| 2016 | 2045.94 Billion KRW | 8.81% |
| 2015 | 1880.32 Billion KRW | 16.36% |
| 2014 | 1615.97 Billion KRW | 6.74% |
| 2013 | 1513.96 Billion KRW | 7.9% |
| 2012 | 1403.08 Billion KRW | 6.77% |
| 2011 | 1314.06 Billion KRW | 4.66% |
| 2010 | 1255.5 Billion KRW | 10.64% |
| 2009 | 1134.79 Billion KRW | 9.23% |
| 2008 | 1038.89 Billion KRW | 4.18% |
| 2007 | 997.18 Billion KRW | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 2885.72 Billion KRW | 3.02% |
| 2024 Q1 | 2801.25 Billion KRW | -0.48% |
| 2023 Q4 | 2814.9 Billion KRW | 5.52% |
| 2023 Q2 | 2505.72 Billion KRW | 0.64% |
| 2023 Q1 | 2489.87 Billion KRW | 0.69% |
| 2023 FY | 2814.07 Billion KRW | 13.8% |
| 2023 Q3 | 2667.61 Billion KRW | 6.46% |
| 2022 Q4 | 2472.72 Billion KRW | 2.29% |
| 2022 Q2 | 2458.38 Billion KRW | -0.92% |
| 2022 Q3 | 2417.26 Billion KRW | -1.67% |
| 2022 Q1 | 2481.09 Billion KRW | 0.7% |
| 2022 FY | 2472.72 Billion KRW | 0.36% |
| 2021 Q3 | 2458.06 Billion KRW | 0.07% |
| 2021 FY | 2463.81 Billion KRW | 2.94% |
| 2021 Q1 | 2512 Billion KRW | 4.95% |
| 2021 Q4 | 2463.81 Billion KRW | 0.23% |
| 2021 Q2 | 2456.42 Billion KRW | -2.21% |
| 2020 Q3 | 2395.27 Billion KRW | 0.51% |
| 2020 Q1 | 2252.41 Billion KRW | 6.39% |
| 2020 Q2 | 2383.03 Billion KRW | 5.8% |
| 2020 Q4 | 2393.52 Billion KRW | -0.07% |
| 2020 FY | 2393.52 Billion KRW | 13.05% |
| 2019 Q3 | 2134.51 Billion KRW | 1.46% |
| 2019 Q1 | 2243.47 Billion KRW | 3.2% |
| 2019 Q4 | 2117.2 Billion KRW | -0.81% |
| 2019 FY | 2117.2 Billion KRW | -2.6% |
| 2019 Q2 | 2103.74 Billion KRW | -6.23% |
| 2018 Q3 | 2150.31 Billion KRW | -0.64% |
| 2018 FY | 2173.81 Billion KRW | 3.78% |
| 2018 Q1 | 2143.3 Billion KRW | 2.32% |
| 2018 Q2 | 2164.06 Billion KRW | 0.97% |
| 2018 Q4 | 2173.81 Billion KRW | 1.09% |
| 2017 Q4 | 2094.67 Billion KRW | 1.35% |
| 2017 FY | 2094.67 Billion KRW | 2.38% |
| 2017 Q1 | 2059.33 Billion KRW | 0.65% |
| 2017 Q2 | 2050.95 Billion KRW | -0.41% |
| 2017 Q3 | 2066.7 Billion KRW | 0.77% |
| 2016 FY | 2045.94 Billion KRW | 8.81% |
| 2016 Q4 | 2045.94 Billion KRW | 0.32% |
| 2016 Q3 | 2039.38 Billion KRW | 0.28% |
| 2016 Q2 | 2033.77 Billion KRW | 5.75% |
| 2016 Q1 | 1923.24 Billion KRW | 2.28% |
| 2015 Q3 | 1770 Billion KRW | 2.66% |
| 2015 Q2 | 1724.19 Billion KRW | 4.02% |
| 2015 FY | 1880.32 Billion KRW | 16.36% |
| 2015 Q1 | 1657.56 Billion KRW | 2.57% |
| 2015 Q4 | 1880.32 Billion KRW | 6.23% |
| 2014 Q3 | 1563.36 Billion KRW | 0.94% |
| 2014 FY | 1615.97 Billion KRW | 6.74% |
| 2014 Q1 | 1525.58 Billion KRW | 0.77% |
| 2014 Q2 | 1548.85 Billion KRW | 1.53% |
| 2014 Q4 | 1615.97 Billion KRW | 3.36% |
| 2013 Q4 | 1513.96 Billion KRW | 1.71% |
| 2013 Q1 | 1453.8 Billion KRW | 3.61% |
| 2013 FY | 1513.96 Billion KRW | 7.9% |
| 2013 Q2 | 1450.95 Billion KRW | -0.2% |
| 2013 Q3 | 1488.46 Billion KRW | 2.59% |
| 2012 Q1 | 1278.38 Billion KRW | 0.0% |
| 2012 FY | 1403.08 Billion KRW | 6.77% |
| 2012 Q4 | 1403.08 Billion KRW | 7.39% |
| 2012 Q3 | 1306.47 Billion KRW | -0.28% |
| 2012 Q2 | 1310.2 Billion KRW | 2.49% |
| 2011 Q1 | 1242.83 Billion KRW | -0.03% |
| 2011 Q2 | 1266.95 Billion KRW | 1.94% |
| 2011 FY | 1314.06 Billion KRW | 4.66% |
| 2011 Q3 | 1265.3 Billion KRW | -0.13% |
| 2010 Q4 | 1243.17 Billion KRW | 3.08% |
| 2010 Q1 | 1142.89 Billion KRW | 2.45% |
| 2010 Q2 | 1175.07 Billion KRW | 2.82% |
| 2010 FY | 1255.5 Billion KRW | 10.64% |
| 2010 Q3 | 1206.02 Billion KRW | 2.63% |
| 2009 Q2 | 1072.04 Billion KRW | 1.47% |
| 2009 Q1 | 1056.56 Billion KRW | 3.48% |
| 2009 FY | 1134.79 Billion KRW | 9.23% |
| 2009 Q4 | 1115.56 Billion KRW | 1.85% |
| 2009 Q3 | 1095.31 Billion KRW | 2.17% |
| 2008 Q1 | 990.54 Billion KRW | 1.84% |
| 2008 Q3 | 1006.54 Billion KRW | -2.45% |
| 2008 FY | 1038.89 Billion KRW | 4.18% |
| 2008 Q4 | 1021.06 Billion KRW | 1.44% |
| 2008 Q2 | 1031.79 Billion KRW | 4.16% |
| 2007 Q3 | 965.82 Billion KRW | 2.84% |
| 2007 Q1 | 942.87 Billion KRW | 0.0% |
| 2007 Q2 | 939.17 Billion KRW | -0.39% |
| 2007 FY | 997.18 Billion KRW | 0.0% |
| 2007 Q4 | 972.62 Billion KRW | 0.7% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Yuyu Pharma, Inc. | 198.21 Billion KRW | -1319.717% |
| Dong-A Socio Holdings Co., Ltd. | 1957.1 Billion KRW | -43.787% |
| Ildong Holdings Co., Ltd. | 876.99 Billion KRW | -220.875% |
| HANDOK Inc. | 790.33 Billion KRW | -256.058% |
| Kukje Pharma Co., Ltd. | 170.61 Billion KRW | -1549.321% |
| Dong-A ST Co., Ltd. | 1315.21 Billion KRW | -113.962% |
| SAMSUNG PHARM. Co., LTD. | 93.47 Billion KRW | -2910.376% |
| Hanmi Pharm. Co., Ltd. | 1952.03 Billion KRW | -44.161% |
| Hanall Biopharma Co.,Ltd | 239.74 Billion KRW | -1073.767% |
| Ilyang Pharmaceutical Co.,Ltd | 468.9 Billion KRW | -500.139% |
| Dong Sung Bio Pharm.Co.,Ltd. | 114.97 Billion KRW | -2347.586% |
| MYUNGMOON Pharm co.,Ltd | 236.54 Billion KRW | -1089.636% |
| Hana Pharm Co., Ltd. | 348.38 Billion KRW | -707.745% |
| Yuyu Pharma, Inc. | 198.21 Billion KRW | -1319.717% |
| Ilsung Pharmaceuticals Co., Ltd. | 419.18 Billion KRW | -571.312% |
| REYON Pharmaceutical Co., Ltd. | 499.77 Billion KRW | -463.067% |
| Aprogen pharmaceuticals,Inc. | 589.39 Billion KRW | -377.449% |
| JW Holdings Corporation | 1176.26 Billion KRW | -139.238% |
| Ildong Pharmaceutical Co., Ltd. | 611.26 Billion KRW | -360.371% |
| Chong Kun Dang Pharmaceutical Corp. | 1402.42 Billion KRW | -100.657% |
| JW Pharmaceutical Corporation | 645.03 Billion KRW | -336.264% |
| Shin Poong Pharm.Co.,Ltd. | 350.08 Billion KRW | -703.828% |
| Hyundai Pharmaceutical Co., Ltd. | 154.04 Billion KRW | -1726.832% |
| Samil Pharmaceutical Co.,Ltd | 370.68 Billion KRW | -659.164% |
| Jeil Pharmaceutical Co.,Ltd | 487.32 Billion KRW | -477.451% |
| Yuyu Pharma, Inc. | 198.21 Billion KRW | -1319.717% |
| Kwang Dong Pharmaceutical Co., Ltd. | 1078.06 Billion KRW | -161.03% |
| Daewoong pharmaceutical Co.,Ltd | 1770.31 Billion KRW | -58.959% |
| JW Pharmaceutical Corporation | 645.03 Billion KRW | -336.264% |
| Yuhan Corporation | 2814.07 Billion KRW | 0.0% |
| Jeil Pharma Holdings Inc | 879.99 Billion KRW | -219.782% |
| Yungjin Pharm. Co., Ltd. | 226.6 Billion KRW | -1141.862% |
| Suheung Co., Ltd. | 993.73 Billion KRW | -183.181% |
| JW Pharmaceutical Corporation | 645.03 Billion KRW | -336.264% |
| Samjin Pharmaceuticals Co., Ltd. | 419.9 Billion KRW | -570.174% |
| Korea United Pharm Inc. | 468.86 Billion KRW | -500.194% |
| CKD Bio Corp. | 293.78 Billion KRW | -857.867% |
| Daewon Pharmaceutical Co., Ltd. | 507.99 Billion KRW | -453.953% |
| Dongwha Pharm.Co.,Ltd | 564.97 Billion KRW | -398.09% |
| Whan In Pharm Co.,Ltd. | 401.22 Billion KRW | -601.367% |
| Shin Poong Pharm.Co.,Ltd. | 350.08 Billion KRW | -703.828% |
| Chong Kun Dang Holdings Corp. | 1456 Billion KRW | -93.274% |
| Boryung Corporation | 922.36 Billion KRW | -205.094% |
| Bukwang Pharmaceutical Co., Ltd. | 442.46 Billion KRW | -536.003% |
| Ilyang Pharmaceutical Co.,Ltd | 468.9 Billion KRW | -500.139% |
| JW Lifescience Corporation | 255.83 Billion KRW | -999.949% |